Immunohistochemically Demonstrated Lymph Node Micrometastasis and Prognosis in Patients With Gallbladder Carcinoma
- 1 July 2006
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Annals of Surgery
- Vol. 244 (1), 99-105
- https://doi.org/10.1097/01.sla.0000217675.22495.6f
Abstract
Objective: To investigate whether immunohistochemically demonstrated lymph node micrometastasis has a survival impact in patients with advanced gallbladder carcinoma (pT2–4 tumors). Summary Background Data: The clinical significance of immunohistochemically detected lymph node micrometastasis recently has been evaluated in various tumors. However, few reports have addressed this issue with regard to gallbladder carcinoma. Methods: A total of 1476 lymph nodes from 67 patients with gallbladder carcinoma (pN0, n = 40; pN1, n = 27) who underwent curative resection were immunostained with monoclonal antibody against cytokeratins 8 and 18. The results were correlated with clinical and pathologic features and with patient survival. Results: Lymph node micrometastases were detected immunohistochemically in 23 (34.3%) of the 67 patients and in 37 (2.5%) of the 1476 nodes examined. Of the 37 nodal micrometastases, 21 (56.8%) were single-cell events, and the remaining 16 were clusters. Five micrometastases were detected in the paraaortic nodes. Clinicopathologic features showed no significant associations with the presence of lymph node micrometastases. Survival was worse in the 27 patients with pN1 disease than in the 40 with pN0 disease (5-year survival; 22.2% vs. 52.6%, P = 0.0038). Similarly, survival was worse in the 23 patients with micrometastasis than in the 44 without micrometastasis (5-year survival; 17.4% vs. 52.7%, P = 0.0027). Twenty-eight patients without any lymph node involvement had the best prognosis, whereas survival for the 11 patients with both types of metastasis was dismal. The grade of micrometastasis (single-cell or cluster) had no effect on survival. The Cox proportional hazard model identified perineural invasion, lymph node micrometastasis, and microscopic venous invasion as significant independent prognostic factors. Conclusions: Lymph node micrometastasis has a significant survival impact in patients with pN0 or pN1 gallbladder carcinoma who underwent macroscopically curative resection. Extensive lymph node sectioning with keratin immunostaining is recommended for accurate prognostic evaluation for patients with gallbladder carcinoma.Keywords
This publication has 34 references indexed in Scilit:
- Immunohistochemically Demonstrated Lymph Node Micrometastasis and Prognosis in Patients With Otherwise Node-Negative Hilar CholangiocarcinomaAnnals of Surgery, 2003
- Lymph node micrometastasis and prognosis in patients with oesophageal squamous cell carcinomaBritish Journal of Surgery, 2001
- Regional and para-aortic lymphadenectomy in radical surgery for advanced gallbladder carcinomaBritish Journal of Surgery, 2000
- Treatment of gallbladder cancer by radical resectionBritish Journal of Surgery, 1999
- Are lymph node micrometastases of any clinical significance in dukes stages A and B colorectal cancer?Diseases of the Colon & Rectum, 1998
- Immunoperoxidase staining for cytokeratins 8 and 18 is very sensitive for detection of occult node metastasis of colorectal cancer: a comparison with genetic analysis of K‐rasHistopathology, 1998
- Long-term results after curative resection for carcinoma of the gallbladderThe American Journal of Surgery, 1998
- Outcome of radical surgery for carcinoma of the gallbladder according to the TNM stageSurgery, 1996
- Clinical significance of occult micrometastasis in lymph nodes from patients with early gastric cancer who died of recurrenceSurgery, 1996
- The prognostic significance of immunohistochemically detected lymph node micrometastases in colorectal carcinomaThe Journal of Pathology, 1994